Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel insights into the treatment of complement-mediated hemolytic anemias
Sigbjørn Berentsen, Anita Hill, Quentin A. Hill, et al.
Therapeutic Advances in Hematology (2019) Vol. 10
Open Access | Times Cited: 161

Showing 1-25 of 161 citing articles:

Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
Ulrich Jäger, Wilma Barcellini, Catherine M. Broome, et al.
Blood Reviews (2019) Vol. 41, pp. 100648-100648
Open Access | Times Cited: 399
Sutimlimab in Cold Agglutinin Disease
Alexander Röth, Wilma Barcellini, Shirley D’Sa, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 14, pp. 1323-1334
Open Access | Times Cited: 156
Autoimmune Hemolytic Anemias
Sigbjørn Berentsen, Wilma Barcellini
New England Journal of Medicine (2021) Vol. 385, Iss. 15, pp. 1407-1419
Closed Access | Times Cited: 140
Tipping the balance: intricate roles of the complement system in disease and therapy
Richard B. Pouw, Daniel Ricklin
Seminars in Immunopathology (2021) Vol. 43, Iss. 6, pp. 757-771
Open Access | Times Cited: 115
Cold agglutinin disease revisited: a multinational, observational study of 232 patients
Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, et al.
Blood (2020) Vol. 136, Iss. 4, pp. 480-488
Open Access | Times Cited: 123
New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
Sigbjørn Berentsen
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 120
How I treat cold agglutinin disease
Sigbjørn Berentsen
Blood (2021) Vol. 137, Iss. 10, pp. 1295-1303
Open Access | Times Cited: 93
C3 inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab
Carlos de Castro, F Grossi, Ilene C. Weitz, et al.
American Journal of Hematology (2020) Vol. 95, Iss. 11, pp. 1334-1343
Open Access | Times Cited: 86
The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?
Sigbjørn Berentsen, Bruno Fattizzo, Wilma Barcellini
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Autoimmune Hemolytic Anemia in the Pediatric Setting
Aikaterini Voulgaridou, Theodosia A. Kalfa
Journal of Clinical Medicine (2021) Vol. 10, Iss. 2, pp. 216-216
Open Access | Times Cited: 48
Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia
Catherine M. Broome, Alexander Röth, David J. Kuter, et al.
Blood Advances (2022) Vol. 7, Iss. 6, pp. 987-996
Open Access | Times Cited: 37
ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies
Ryan Philip Jajosky, Shang‐Chuen Wu, Léon Zheng, et al.
iScience (2022) Vol. 26, Iss. 1, pp. 105798-105798
Open Access | Times Cited: 37
Sutimlimab for Treatment of Cold Agglutinin Disease: Why, How And For Whom?
Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, et al.
Immunotherapy (2022) Vol. 14, Iss. 15, pp. 1191-1204
Open Access | Times Cited: 33
Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis
Li-Chung Tsao, Erika J. Crosby, Timothy N. Trotter, et al.
JCI Insight (2022) Vol. 7, Iss. 6
Open Access | Times Cited: 29
Cutting-Edge Techniques and Drugs for the Treatment of Pulmonary Embolism: Current Knowledge and Future Perspectives
Lorenzo Falsetti, Emanuele Guerrieri, Vincenzo Zaccone, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1952-1952
Open Access | Times Cited: 6
Exploiting protease activation for therapy
Chloe Bleuez, Wolfgang F. Koch, Carole Urbach, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 6, pp. 1743-1754
Open Access | Times Cited: 23
Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double‐blind, placebo‐controlled, global study (FORWARD)
David J. Kuter, Caroline I. Piatek, Alexander Röth, et al.
American Journal of Hematology (2023) Vol. 99, Iss. 1, pp. 79-87
Open Access | Times Cited: 15
Complement C1s as a diagnostic marker and therapeutic target: Progress and propective
Jun Ye, Peng Yang, Yili Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Reeling in complement in transplant‐associated thrombotic microangiopathy: You're going to need a bigger boat
Sonata Jodele, Anthony Sabulski
American Journal of Hematology (2023) Vol. 98, Iss. S4
Open Access | Times Cited: 11
Managing anti-factor H antibody-associated hemolytic uremic syndrome: time for consensus
Priyanka Khandelwal, Arvind Bagga
Pediatric Nephrology (2024) Vol. 39, Iss. 11, pp. 3137-3141
Open Access | Times Cited: 3
Autoimmune haemolytic anaemias
Marc Michel, Étienne Crickx, Bruno Fattizzo, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 3
Infectious Complications in Autoimmune Hemolytic Anemia
Juri Alessandro Giannotta, Bruno Fattizzo, Francesca Cavallaro, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 1, pp. 164-164
Open Access | Times Cited: 23
Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia
Irina Murakhovskaya
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 4034-4034
Open Access | Times Cited: 22
Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study
Alexander Röth, Wilma Barcellini, Tor Henrik Anderson Tvedt, et al.
Annals of Hematology (2022) Vol. 101, Iss. 10, pp. 2169-2177
Open Access | Times Cited: 13
Monoclonal antibodies for treatment of cold agglutinin disease
Georg Gelbenegger, Sigbjørn Berentsen, Bernd Jilma
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 5, pp. 395-406
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top